Latest News
Feature
From Frankenstein to Lecter: Hollywood’s baddest docs
When Dr. Frankenstein exclaims: “It’s alive, it’s alive!” little did he...
From the Journals
Gene ‘cut-and-paste’ treatment could offer hope for inherited immune system diseases
“Collecting the T cells is easier and correcting the T cells is easier. With this approach the amount of time in hospital the patients would need...
Feature
Is it flu, RSV, or COVID? Experts fear the ‘tripledemic’
Predicting exactly when cases will peak is difficult.
From the Journals
Two biologics equally effective for extraintestinal manifestations of IBD
Ustekinumab and vedolizumab have similar effects on extraintestinal manifestations of inflammatory bowel disease, a real-world, retrospective...
From the Journals
Vitamin D deficiency linked to death, new study finds
A genetic approach provides support for the effects of vitamin D on mortality. The benefits of vitamin D supplementation are largely found in...
Conference Coverage
Achieving diversity, equity and inclusion: Invite everyone and build a team
Don’t recruit diverse people to your program and then have them come and feel not included.
Feature
Worse COVID outcomes seen with gout, particularly in women
People with gout, especially women, may be at higher risk for poor COVID-19 outcomes, including hospitalization and death, researchers report.
News
Less than 6 hours of sleep a night linked to serious, chronic illness
Chronic health problems can interrupt sleep. “Which is the chicken, and which is the egg?”
News from the FDA/CDC
FDA approves upadacitinib (Rinvoq) for sixth indication
Upadacitinib’s approval for nonradiographic axial spondyloarthritis marks the sixth indication in the United States for the Janus kinase inhibitor...
From the Journals
Psoriatic arthritis has greater impact on women than men
Women with PsA were more likely to have worse disease burden, pain, fatigue, quality of life, and greater disability and work impairment compared...
From the Journals
Ten-day methotrexate pause after COVID vaccine booster enhances immunity against Omicron variant
Researchers in Germany report a 10-day post-vaccination hold on methotrexate boosts immunity against Omicron without compromising safety or risk...